カテゴリ： QYResearch, 世界, 医療/バイオ

フラタキシンミトコンドリアの世界市場2023年：フリードライヒ失調症タンパク質、FXN、EC 1.16.3.1

■ 英語タイトル：Global Frataxin Mitochondrial Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8764）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8764
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：100
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[フラタキシンミトコンドリアの世界市場2023年：フリードライヒ失調症タンパク質、FXN、EC 1.16.3.1]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はフラタキシンミトコンドリアのグローバル市場について調査・分析し、世界のフラタキシンミトコンドリア市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（フリードライヒ失調症タンパク質、FXN、EC 1.16.3.1）、用途別セグメント分析（中枢神経系、循環器系）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、AavantiBio Inc、Adverum Biotechnologies Inc、Anima Biotech Inc、Biointaxis SL、Cellivery Therapeutics Inc、CRISPR Therapeutics AG、Design Therapeutics Inc、Fratagene Therapeutics Srl、Fulcrum Therapeutics Inc、Jupiter Orphan Therapeutics Inc、Lacerta Therapeutics Inc、Larimar Therapeutics Inc、Novartis Gene Therapies、PTC Therapeutics Inc、Voyager Therapeutics Incなどが含まれています。フラタキシンミトコンドリアのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、フラタキシンミトコンドリア市場規模を算出する際に考慮しました。

・フラタキシンミトコンドリア市場の概要
- 製品の定義
- フラタキシンミトコンドリアの種類別セグメント
- 世界のフラタキシンミトコンドリア市場規模：タイプ別分析（フリードライヒ失調症タンパク質、FXN、EC 1.16.3.1）
- フラタキシンミトコンドリアの用途別セグメント
- 世界のフラタキシンミトコンドリア市場規模：用途別分析（中枢神経系、循環器系）
- 世界のフラタキシンミトコンドリア市場規模予測（2018年-2029年）
- フラタキシンミトコンドリアの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- フラタキシンミトコンドリア市場の競争状況およびトレンド

・フラタキシンミトコンドリアの地域別市場規模
- 北米のフラタキシンミトコンドリア市場規模（2018年-2029年）
- 米国のフラタキシンミトコンドリア市場規模（2018年-2029年）
- ヨーロッパのフラタキシンミトコンドリア市場規模（2018年-2029年）
- アジア太平洋のフラタキシンミトコンドリア市場規模（2018年-2029年）
- 中国のフラタキシンミトコンドリア市場規模（2018年-2029年）
- 日本のフラタキシンミトコンドリア市場規模（2018年-2029年）
- 韓国のフラタキシンミトコンドリア市場規模（2018年-2029年）
- インドのフラタキシンミトコンドリア市場規模（2018年-2029年）
- オーストラリアのフラタキシンミトコンドリア市場規模（2018年-2029年）
- 中南米のフラタキシンミトコンドリア市場規模（2018年-2029年）
- 中東・アフリカのフラタキシンミトコンドリア市場規模（2018年-2029年）

・種類別セグメント：フリードライヒ失調症タンパク質、FXN、EC 1.16.3.1
- 世界のフラタキシンミトコンドリアのタイプ別販売量（2018年-2023年）
- 世界のフラタキシンミトコンドリアのタイプ別売上（2018年-2023年）
- 世界のフラタキシンミトコンドリアのタイプ別価格

・用途別セグメント：中枢神経系、循環器系
- 世界のフラタキシンミトコンドリアの用途別販売量（2018年-2023年）
- 世界のフラタキシンミトコンドリアの用途別売上（2018年-2023年）
- 世界のフラタキシンミトコンドリアの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
AavantiBio Inc、Adverum Biotechnologies Inc、Anima Biotech Inc、Biointaxis SL、Cellivery Therapeutics Inc、CRISPR Therapeutics AG、Design Therapeutics Inc、Fratagene Therapeutics Srl、Fulcrum Therapeutics Inc、Jupiter Orphan Therapeutics Inc、Lacerta Therapeutics Inc、Larimar Therapeutics Inc、Novartis Gene Therapies、PTC Therapeutics Inc、Voyager Therapeutics Inc

・産業チェーンと販売チャネルの分析
- フラタキシンミトコンドリア産業チェーン分析
- フラタキシンミトコンドリアの主要原材料
- フラタキシンミトコンドリアの販売チャネル
- フラタキシンミトコンドリアのディストリビューター
- フラタキシンミトコンドリアの主要顧客

・フラタキシンミトコンドリア市場ダイナミクス
- フラタキシンミトコンドリアの業界動向
- フラタキシンミトコンドリア市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) – Frataxin is a protein encoded by the FXN gene. It promotes the biosynthesis of heme and assembly and repair of iron-sulfur clusters by delivering Fe2+ to proteins involved in these pathways. It plays a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe2+ to Fe3.
Highlights
The global Frataxin Mitochondrial market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Frataxin Mitochondrial is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Frataxin Mitochondrial is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Frataxin Mitochondrial include AavantiBio Inc, Adverum Biotechnologies Inc, Anima Biotech Inc, Biointaxis SL, Cellivery Therapeutics Inc, CRISPR Therapeutics AG, Design Therapeutics Inc, Fratagene Therapeutics Srl and Fulcrum Therapeutics Inc, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Frataxin Mitochondrial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Frataxin Mitochondrial.
The Frataxin Mitochondrial market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Frataxin Mitochondrial market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Frataxin Mitochondrial manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AavantiBio Inc
Adverum Biotechnologies Inc
Anima Biotech Inc
Biointaxis SL
Cellivery Therapeutics Inc
CRISPR Therapeutics AG
Design Therapeutics Inc
Fratagene Therapeutics Srl
Fulcrum Therapeutics Inc
Jupiter Orphan Therapeutics Inc
Lacerta Therapeutics Inc
Larimar Therapeutics Inc
Novartis Gene Therapies
PTC Therapeutics Inc
Voyager Therapeutics Inc
Segment by Type
Friedreich Ataxia Protein
FXN
EC 1.16.3.1
Segment by Application
Central Nervous System
Cardiovascular
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Frataxin Mitochondrial manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Frataxin Mitochondrial in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Frataxin Mitochondrial Market Overview
1.1 Product Overview and Scope of Frataxin Mitochondrial
1.2 Frataxin Mitochondrial Segment by Type
1.2.1 Global Frataxin Mitochondrial Market Value Comparison by Type (2023-2029)
1.2.2 Friedreich Ataxia Protein
1.2.3 FXN
1.2.4 EC 1.16.3.1
1.3 Frataxin Mitochondrial Segment by Application
1.3.1 Global Frataxin Mitochondrial Market Value by Application: (2023-2029)
1.3.2 Central Nervous System
1.3.3 Cardiovascular
1.4 Global Frataxin Mitochondrial Market Size Estimates and Forecasts
1.4.1 Global Frataxin Mitochondrial Revenue 2018-2029
1.4.2 Global Frataxin Mitochondrial Sales 2018-2029
1.4.3 Global Frataxin Mitochondrial Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Frataxin Mitochondrial Market Competition by Manufacturers
2.1 Global Frataxin Mitochondrial Sales Market Share by Manufacturers (2018-2023)
2.2 Global Frataxin Mitochondrial Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Frataxin Mitochondrial Average Price by Manufacturers (2018-2023)
2.4 Global Frataxin Mitochondrial Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Frataxin Mitochondrial, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Frataxin Mitochondrial, Product Type & Application
2.7 Frataxin Mitochondrial Market Competitive Situation and Trends
2.7.1 Frataxin Mitochondrial Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Frataxin Mitochondrial Players Market Share by Revenue
2.7.3 Global Frataxin Mitochondrial Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Frataxin Mitochondrial Retrospective Market Scenario by Region
3.1 Global Frataxin Mitochondrial Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Frataxin Mitochondrial Global Frataxin Mitochondrial Sales by Region: 2018-2029
3.2.1 Global Frataxin Mitochondrial Sales by Region: 2018-2023
3.2.2 Global Frataxin Mitochondrial Sales by Region: 2024-2029
3.3 Global Frataxin Mitochondrial Global Frataxin Mitochondrial Revenue by Region: 2018-2029
3.3.1 Global Frataxin Mitochondrial Revenue by Region: 2018-2023
3.3.2 Global Frataxin Mitochondrial Revenue by Region: 2024-2029
3.4 North America Frataxin Mitochondrial Market Facts & Figures by Country
3.4.1 North America Frataxin Mitochondrial Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Frataxin Mitochondrial Sales by Country (2018-2029)
3.4.3 North America Frataxin Mitochondrial Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Frataxin Mitochondrial Market Facts & Figures by Country
3.5.1 Europe Frataxin Mitochondrial Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Frataxin Mitochondrial Sales by Country (2018-2029)
3.5.3 Europe Frataxin Mitochondrial Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Frataxin Mitochondrial Market Facts & Figures by Country
3.6.1 Asia Pacific Frataxin Mitochondrial Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Frataxin Mitochondrial Sales by Country (2018-2029)
3.6.3 Asia Pacific Frataxin Mitochondrial Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Frataxin Mitochondrial Market Facts & Figures by Country
3.7.1 Latin America Frataxin Mitochondrial Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Frataxin Mitochondrial Sales by Country (2018-2029)
3.7.3 Latin America Frataxin Mitochondrial Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Frataxin Mitochondrial Market Facts & Figures by Country
3.8.1 Middle East and Africa Frataxin Mitochondrial Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Frataxin Mitochondrial Sales by Country (2018-2029)
3.8.3 Middle East and Africa Frataxin Mitochondrial Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Frataxin Mitochondrial Sales by Type (2018-2029)
4.1.1 Global Frataxin Mitochondrial Sales by Type (2018-2023)
4.1.2 Global Frataxin Mitochondrial Sales by Type (2024-2029)
4.1.3 Global Frataxin Mitochondrial Sales Market Share by Type (2018-2029)
4.2 Global Frataxin Mitochondrial Revenue by Type (2018-2029)
4.2.1 Global Frataxin Mitochondrial Revenue by Type (2018-2023)
4.2.2 Global Frataxin Mitochondrial Revenue by Type (2024-2029)
4.2.3 Global Frataxin Mitochondrial Revenue Market Share by Type (2018-2029)
4.3 Global Frataxin Mitochondrial Price by Type (2018-2029)
5 Segment by Application
5.1 Global Frataxin Mitochondrial Sales by Application (2018-2029)
5.1.1 Global Frataxin Mitochondrial Sales by Application (2018-2023)
5.1.2 Global Frataxin Mitochondrial Sales by Application (2024-2029)
5.1.3 Global Frataxin Mitochondrial Sales Market Share by Application (2018-2029)
5.2 Global Frataxin Mitochondrial Revenue by Application (2018-2029)
5.2.1 Global Frataxin Mitochondrial Revenue by Application (2018-2023)
5.2.2 Global Frataxin Mitochondrial Revenue by Application (2024-2029)
5.2.3 Global Frataxin Mitochondrial Revenue Market Share by Application (2018-2029)
5.3 Global Frataxin Mitochondrial Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AavantiBio Inc
6.1.1 AavantiBio Inc Corporation Information
6.1.2 AavantiBio Inc Description and Business Overview
6.1.3 AavantiBio Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AavantiBio Inc Frataxin Mitochondrial Product Portfolio
6.1.5 AavantiBio Inc Recent Developments/Updates
6.2 Adverum Biotechnologies Inc
6.2.1 Adverum Biotechnologies Inc Corporation Information
6.2.2 Adverum Biotechnologies Inc Description and Business Overview
6.2.3 Adverum Biotechnologies Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Adverum Biotechnologies Inc Frataxin Mitochondrial Product Portfolio
6.2.5 Adverum Biotechnologies Inc Recent Developments/Updates
6.3 Anima Biotech Inc
6.3.1 Anima Biotech Inc Corporation Information
6.3.2 Anima Biotech Inc Description and Business Overview
6.3.3 Anima Biotech Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Anima Biotech Inc Frataxin Mitochondrial Product Portfolio
6.3.5 Anima Biotech Inc Recent Developments/Updates
6.4 Biointaxis SL
6.4.1 Biointaxis SL Corporation Information
6.4.2 Biointaxis SL Description and Business Overview
6.4.3 Biointaxis SL Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biointaxis SL Frataxin Mitochondrial Product Portfolio
6.4.5 Biointaxis SL Recent Developments/Updates
6.5 Cellivery Therapeutics Inc
6.5.1 Cellivery Therapeutics Inc Corporation Information
6.5.2 Cellivery Therapeutics Inc Description and Business Overview
6.5.3 Cellivery Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cellivery Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.5.5 Cellivery Therapeutics Inc Recent Developments/Updates
6.6 CRISPR Therapeutics AG
6.6.1 CRISPR Therapeutics AG Corporation Information
6.6.2 CRISPR Therapeutics AG Description and Business Overview
6.6.3 CRISPR Therapeutics AG Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CRISPR Therapeutics AG Frataxin Mitochondrial Product Portfolio
6.6.5 CRISPR Therapeutics AG Recent Developments/Updates
6.7 Design Therapeutics Inc
6.6.1 Design Therapeutics Inc Corporation Information
6.6.2 Design Therapeutics Inc Description and Business Overview
6.6.3 Design Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Design Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.7.5 Design Therapeutics Inc Recent Developments/Updates
6.8 Fratagene Therapeutics Srl
6.8.1 Fratagene Therapeutics Srl Corporation Information
6.8.2 Fratagene Therapeutics Srl Description and Business Overview
6.8.3 Fratagene Therapeutics Srl Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Fratagene Therapeutics Srl Frataxin Mitochondrial Product Portfolio
6.8.5 Fratagene Therapeutics Srl Recent Developments/Updates
6.9 Fulcrum Therapeutics Inc
6.9.1 Fulcrum Therapeutics Inc Corporation Information
6.9.2 Fulcrum Therapeutics Inc Description and Business Overview
6.9.3 Fulcrum Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Fulcrum Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.9.5 Fulcrum Therapeutics Inc Recent Developments/Updates
6.10 Jupiter Orphan Therapeutics Inc
6.10.1 Jupiter Orphan Therapeutics Inc Corporation Information
6.10.2 Jupiter Orphan Therapeutics Inc Description and Business Overview
6.10.3 Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.10.5 Jupiter Orphan Therapeutics Inc Recent Developments/Updates
6.11 Lacerta Therapeutics Inc
6.11.1 Lacerta Therapeutics Inc Corporation Information
6.11.2 Lacerta Therapeutics Inc Frataxin Mitochondrial Description and Business Overview
6.11.3 Lacerta Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Lacerta Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.11.5 Lacerta Therapeutics Inc Recent Developments/Updates
6.12 Larimar Therapeutics Inc
6.12.1 Larimar Therapeutics Inc Corporation Information
6.12.2 Larimar Therapeutics Inc Frataxin Mitochondrial Description and Business Overview
6.12.3 Larimar Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Larimar Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.12.5 Larimar Therapeutics Inc Recent Developments/Updates
6.13 Novartis Gene Therapies
6.13.1 Novartis Gene Therapies Corporation Information
6.13.2 Novartis Gene Therapies Frataxin Mitochondrial Description and Business Overview
6.13.3 Novartis Gene Therapies Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Novartis Gene Therapies Frataxin Mitochondrial Product Portfolio
6.13.5 Novartis Gene Therapies Recent Developments/Updates
6.14 PTC Therapeutics Inc
6.14.1 PTC Therapeutics Inc Corporation Information
6.14.2 PTC Therapeutics Inc Frataxin Mitochondrial Description and Business Overview
6.14.3 PTC Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.14.4 PTC Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.14.5 PTC Therapeutics Inc Recent Developments/Updates
6.15 Voyager Therapeutics Inc
6.15.1 Voyager Therapeutics Inc Corporation Information
6.15.2 Voyager Therapeutics Inc Frataxin Mitochondrial Description and Business Overview
6.15.3 Voyager Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Voyager Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.15.5 Voyager Therapeutics Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Frataxin Mitochondrial Industry Chain Analysis
7.2 Frataxin Mitochondrial Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Frataxin Mitochondrial Production Mode & Process
7.4 Frataxin Mitochondrial Sales and Marketing
7.4.1 Frataxin Mitochondrial Sales Channels
7.4.2 Frataxin Mitochondrial Distributors
7.5 Frataxin Mitochondrial Customers
8 Frataxin Mitochondrial Market Dynamics
8.1 Frataxin Mitochondrial Industry Trends
8.2 Frataxin Mitochondrial Market Drivers
8.3 Frataxin Mitochondrial Market Challenges
8.4 Frataxin Mitochondrial Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Frataxin Mitochondrial Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Frataxin Mitochondrial Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Frataxin Mitochondrial Market Competitive Situation by Manufacturers in 2022
Table 4. Global Frataxin Mitochondrial Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Frataxin Mitochondrial Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Frataxin Mitochondrial Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Frataxin Mitochondrial Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Frataxin Mitochondrial Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Frataxin Mitochondrial, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Frataxin Mitochondrial, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Frataxin Mitochondrial, Product Type & Application
Table 12. Global Key Manufacturers of Frataxin Mitochondrial, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Frataxin Mitochondrial by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Frataxin Mitochondrial as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Frataxin Mitochondrial Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Frataxin Mitochondrial Sales by Region (2018-2023) & (K Units)
Table 18. Global Frataxin Mitochondrial Sales Market Share by Region (2018-2023)
Table 19. Global Frataxin Mitochondrial Sales by Region (2024-2029) & (K Units)
Table 20. Global Frataxin Mitochondrial Sales Market Share by Region (2024-2029)
Table 21. Global Frataxin Mitochondrial Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Frataxin Mitochondrial Revenue Market Share by Region (2018-2023)
Table 23. Global Frataxin Mitochondrial Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Frataxin Mitochondrial Revenue Market Share by Region (2024-2029)
Table 25. North America Frataxin Mitochondrial Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Frataxin Mitochondrial Sales by Country (2018-2023) & (K Units)
Table 27. North America Frataxin Mitochondrial Sales by Country (2024-2029) & (K Units)
Table 28. North America Frataxin Mitochondrial Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Frataxin Mitochondrial Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Frataxin Mitochondrial Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Frataxin Mitochondrial Sales by Country (2018-2023) & (K Units)
Table 32. Europe Frataxin Mitochondrial Sales by Country (2024-2029) & (K Units)
Table 33. Europe Frataxin Mitochondrial Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Frataxin Mitochondrial Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Frataxin Mitochondrial Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Frataxin Mitochondrial Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Frataxin Mitochondrial Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Frataxin Mitochondrial Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Frataxin Mitochondrial Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Frataxin Mitochondrial Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Frataxin Mitochondrial Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Frataxin Mitochondrial Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Frataxin Mitochondrial Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Frataxin Mitochondrial Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Frataxin Mitochondrial Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Frataxin Mitochondrial Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Frataxin Mitochondrial Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Frataxin Mitochondrial Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Frataxin Mitochondrial Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Frataxin Mitochondrial Sales (K Units) by Type (2018-2023)
Table 51. Global Frataxin Mitochondrial Sales (K Units) by Type (2024-2029)
Table 52. Global Frataxin Mitochondrial Sales Market Share by Type (2018-2023)
Table 53. Global Frataxin Mitochondrial Sales Market Share by Type (2024-2029)
Table 54. Global Frataxin Mitochondrial Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Frataxin Mitochondrial Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Frataxin Mitochondrial Revenue Market Share by Type (2018-2023)
Table 57. Global Frataxin Mitochondrial Revenue Market Share by Type (2024-2029)
Table 58. Global Frataxin Mitochondrial Price (US$/Unit) by Type (2018-2023)
Table 59. Global Frataxin Mitochondrial Price (US$/Unit) by Type (2024-2029)
Table 60. Global Frataxin Mitochondrial Sales (K Units) by Application (2018-2023)
Table 61. Global Frataxin Mitochondrial Sales (K Units) by Application (2024-2029)
Table 62. Global Frataxin Mitochondrial Sales Market Share by Application (2018-2023)
Table 63. Global Frataxin Mitochondrial Sales Market Share by Application (2024-2029)
Table 64. Global Frataxin Mitochondrial Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Frataxin Mitochondrial Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Frataxin Mitochondrial Revenue Market Share by Application (2018-2023)
Table 67. Global Frataxin Mitochondrial Revenue Market Share by Application (2024-2029)
Table 68. Global Frataxin Mitochondrial Price (US$/Unit) by Application (2018-2023)
Table 69. Global Frataxin Mitochondrial Price (US$/Unit) by Application (2024-2029)
Table 70. AavantiBio Inc Corporation Information
Table 71. AavantiBio Inc Description and Business Overview
Table 72. AavantiBio Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. AavantiBio Inc Frataxin Mitochondrial Product
Table 74. AavantiBio Inc Recent Developments/Updates
Table 75. Adverum Biotechnologies Inc Corporation Information
Table 76. Adverum Biotechnologies Inc Description and Business Overview
Table 77. Adverum Biotechnologies Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Adverum Biotechnologies Inc Frataxin Mitochondrial Product
Table 79. Adverum Biotechnologies Inc Recent Developments/Updates
Table 80. Anima Biotech Inc Corporation Information
Table 81. Anima Biotech Inc Description and Business Overview
Table 82. Anima Biotech Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Anima Biotech Inc Frataxin Mitochondrial Product
Table 84. Anima Biotech Inc Recent Developments/Updates
Table 85. Biointaxis SL Corporation Information
Table 86. Biointaxis SL Description and Business Overview
Table 87. Biointaxis SL Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Biointaxis SL Frataxin Mitochondrial Product
Table 89. Biointaxis SL Recent Developments/Updates
Table 90. Cellivery Therapeutics Inc Corporation Information
Table 91. Cellivery Therapeutics Inc Description and Business Overview
Table 92. Cellivery Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Cellivery Therapeutics Inc Frataxin Mitochondrial Product
Table 94. Cellivery Therapeutics Inc Recent Developments/Updates
Table 95. CRISPR Therapeutics AG Corporation Information
Table 96. CRISPR Therapeutics AG Description and Business Overview
Table 97. CRISPR Therapeutics AG Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. CRISPR Therapeutics AG Frataxin Mitochondrial Product
Table 99. CRISPR Therapeutics AG Recent Developments/Updates
Table 100. Design Therapeutics Inc Corporation Information
Table 101. Design Therapeutics Inc Description and Business Overview
Table 102. Design Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Design Therapeutics Inc Frataxin Mitochondrial Product
Table 104. Design Therapeutics Inc Recent Developments/Updates
Table 105. Fratagene Therapeutics Srl Corporation Information
Table 106. Fratagene Therapeutics Srl Description and Business Overview
Table 107. Fratagene Therapeutics Srl Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Fratagene Therapeutics Srl Frataxin Mitochondrial Product
Table 109. Fratagene Therapeutics Srl Recent Developments/Updates
Table 110. Fulcrum Therapeutics Inc Corporation Information
Table 111. Fulcrum Therapeutics Inc Description and Business Overview
Table 112. Fulcrum Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Fulcrum Therapeutics Inc Frataxin Mitochondrial Product
Table 114. Fulcrum Therapeutics Inc Recent Developments/Updates
Table 115. Jupiter Orphan Therapeutics Inc Corporation Information
Table 116. Jupiter Orphan Therapeutics Inc Description and Business Overview
Table 117. Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Product
Table 119. Jupiter Orphan Therapeutics Inc Recent Developments/Updates
Table 120. Lacerta Therapeutics Inc Corporation Information
Table 121. Lacerta Therapeutics Inc Description and Business Overview
Table 122. Lacerta Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Lacerta Therapeutics Inc Frataxin Mitochondrial Product
Table 124. Lacerta Therapeutics Inc Recent Developments/Updates
Table 125. Larimar Therapeutics Inc Corporation Information
Table 126. Larimar Therapeutics Inc Description and Business Overview
Table 127. Larimar Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Larimar Therapeutics Inc Frataxin Mitochondrial Product
Table 129. Larimar Therapeutics Inc Recent Developments/Updates
Table 130. Novartis Gene Therapies Corporation Information
Table 131. Novartis Gene Therapies Description and Business Overview
Table 132. Novartis Gene Therapies Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Novartis Gene Therapies Frataxin Mitochondrial Product
Table 134. Novartis Gene Therapies Recent Developments/Updates
Table 135. PTC Therapeutics Inc Corporation Information
Table 136. PTC Therapeutics Inc Description and Business Overview
Table 137. PTC Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. PTC Therapeutics Inc Frataxin Mitochondrial Product
Table 139. PTC Therapeutics Inc Recent Developments/Updates
Table 140. Voyager Therapeutics Inc Corporation Information
Table 141. Voyager Therapeutics Inc Description and Business Overview
Table 142. Voyager Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Voyager Therapeutics Inc Frataxin Mitochondrial Product
Table 144. Voyager Therapeutics Inc Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Frataxin Mitochondrial Distributors List
Table 148. Frataxin Mitochondrial Customers List
Table 149. Frataxin Mitochondrial Market Trends
Table 150. Frataxin Mitochondrial Market Drivers
Table 151. Frataxin Mitochondrial Market Challenges
Table 152. Frataxin Mitochondrial Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Frataxin Mitochondrial
Figure 2. Global Frataxin Mitochondrial Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Frataxin Mitochondrial Market Share by Type in 2022 & 2029
Figure 4. Friedreich Ataxia Protein Product Picture
Figure 5. FXN Product Picture
Figure 6. EC 1.16.3.1 Product Picture
Figure 7. Global Frataxin Mitochondrial Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Frataxin Mitochondrial Market Share by Application in 2022 & 2029
Figure 9. Central Nervous System
Figure 10. Cardiovascular
Figure 11. Global Frataxin Mitochondrial Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Frataxin Mitochondrial Market Size (2018-2029) & (US$ Million)
Figure 13. Global Frataxin Mitochondrial Sales (2018-2029) & (K Units)
Figure 14. Global Frataxin Mitochondrial Average Price (US$/Unit) & (2018-2029)
Figure 15. Frataxin Mitochondrial Report Years Considered
Figure 16. Frataxin Mitochondrial Sales Share by Manufacturers in 2022
Figure 17. Global Frataxin Mitochondrial Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Frataxin Mitochondrial Players: Market Share by Revenue in 2022
Figure 19. Frataxin Mitochondrial Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Frataxin Mitochondrial Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Frataxin Mitochondrial Sales Market Share by Country (2018-2029)
Figure 22. North America Frataxin Mitochondrial Revenue Market Share by Country (2018-2029)
Figure 23. United States Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Frataxin Mitochondrial Sales Market Share by Country (2018-2029)
Figure 26. Europe Frataxin Mitochondrial Revenue Market Share by Country (2018-2029)
Figure 27. Germany Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Frataxin Mitochondrial Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Frataxin Mitochondrial Revenue Market Share by Region (2018-2029)
Figure 34. China Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Frataxin Mitochondrial Sales Market Share by Country (2018-2029)
Figure 44. Latin America Frataxin Mitochondrial Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Frataxin Mitochondrial Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Frataxin Mitochondrial Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Frataxin Mitochondrial Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Frataxin Mitochondrial by Type (2018-2029)
Figure 54. Global Revenue Market Share of Frataxin Mitochondrial by Type (2018-2029)
Figure 55. Global Frataxin Mitochondrial Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Frataxin Mitochondrial by Application (2018-2029)
Figure 57. Global Revenue Market Share of Frataxin Mitochondrial by Application (2018-2029)
Figure 58. Global Frataxin Mitochondrial Price (US$/Unit) by Application (2018-2029)
Figure 59. Frataxin Mitochondrial Value Chain
Figure 60. Frataxin Mitochondrial Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ミトコンドリア複合体活性アッセイキットのグローバル市場予測2023-2029
  • ミトコンドリア呼吸鎖複合体ELISA（酵素結合免疫吸着測定）キットのグローバル市場予測2023-2029
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8764 )"フラタキシンミトコンドリアの世界市場2023年：フリードライヒ失調症タンパク質、FXN、EC 1.16.3.1" (英文：Global Frataxin Mitochondrial Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。